Business & Development
-
Broker tips: AstraZeneca, Enquest, FirstGroup
Analysts at Berenberg reiterated their ‘buy’ recommendation with a 120.0p target price for shares of AstraZeneca following the release of the company’s…
-
Berenberg stays at ‘buy’ for AstraZeneca after trial results for Enhertu against breast cancer
Analysts at Berenberg reiterated their ‘buy’ recommendation with a 120.0p target price for shares of AstraZeneca following the release of the company’s…
-
RBC hikes FirstGroup target price, says I Squared offer undervalues company
Analysts at RBC hiked their target price for shares of First Group on the back of improved estimates for the company’s UK…
-
Barclays downgrades Enquest to ‘underweight’ due to government levy
Analysts at Barclays downgraded their recommendation for shares of Enquest on the back of the government’s recently announced plan for a levy…
-
RBC hikes First Group target price, says I Squared offer undervalues company
Analysts at RBC hiked their target price for shares of First Group on the back of improved estimates for the company’s UK…
-
JP Morgan thinks risk-reward for equities will likely improve going into 2H
Equity strategists at JP Morgan sounded a relatively upbeat note on the outlook for stocks globally. “We believe that the fundamental risk-reward…
-
M&C Saatchi removes Vin Murria from board
UK ad agency M&C Saatchi on Monday removed Vin Murria, its largest shareholder, from its board, the company said, after rebuffing his…
-
Broker tips: B&M, Impax Asset Management
Analysts at Berenberg lowered their target price on asset manager Impax from 1,350.0p to 1,250.0p on Wednesday as ongoing market volatility had…
-
Berenberg lowers target price on Impax Asset Management
Analysts at Berenberg lowered their target price on asset manager Impax from 1,350.0p to 1,250.0p on Wednesday as ongoing market volatility had…
-
Deutsche Bank upgrades B&M to ‘hold’, lowers target price
Analysts at Deutsche Bank upgraded their rating on retailer B&M from ‘sell’ to ‘hold’ on Wednesday, stating earnings risks were increasing but…
Wealth DFM Talk is our flagship podcast, that fits perfectly into your busy life, bringing the latest insight, analysis, news and interviews to you, wherever you are.
Wealth DFM Talk Podcast – listen to the latest episode
